$46.71
À la fermeture: Aug 27, 4:57 PM EDT
$47.14
0.430.92%
Après les heures de négociation: 4:57 PM EDT
Comments
Loading...
Activité de trading des initiés
Suivez les dernières activités de délit d'initié Exact Sciences. Restez informé des achats, des ventes et de l'impact sur le marché des actions Exact Sciences.
Qu’est-ce que l’activité d’initié ?
L'activité de délit d'initié implique des initiés de l'entreprise, tels que des dirigeants, des administrateurs et des employés, qui s'engagent dans des transactions sur les actions de leur propre entreprise. Les transactions d'achat et de vente des initiés fournissent des informations précieuses sur leur confiance dans les performances futures de l'entreprise.
Que font les Exact Sciences Corp Insiders ?
À Exact Sciences Corp, une activité interne récente a attiré l'attention. Au cours des 30 derniers jours, les initiés ont déclaré avoir vendu un total de 1.49K actions d'une valeur de $62.40K. ne signalez aucun achat au cours des 30 derniers jours.
Achats et ventes récents notables d’initiés
- Le août 14, 2025 James Edward Doyle, le - sold 1.49K actions pour $42.02 chacune.
Statistiques de propriété pour Exact Sciences Corp
Actions en circulation
189.319M
Actions détenues par les initiés
3.956M
Pourcentage d'actions détenu par les initiés
2.10%
Actions détenues par les institutions
159.307M
Pourcentage d'actions détenu par les institutions
84.2%
Aug 14, 2025 | — | -1.49K | $42.02 | -$62.40K | SELL | -2.42% | 59.96K | Aug 13 | ||
Jun 16, 2025 | — | 2.19K | $53.20 | -$170.61K | GRANT | 3.10% | 72.76K | Jun 12 - Jun 13 | ||
Nov 13, 2024 | PRESIDENT AND CEO | 19.50K | $51.35 | $1.00M | BUY | 1.69% | 1.18M | Nov 13 | ||
Oct 09, 2024 | EVP, GM, PRECISION ONCOLOGY | -929.00 | $70.00 | -$65.03K | SELL | -6.57% | 13.21K | Oct 08 | ||
Sep 19, 2024 | EVP, GM, PRECISION ONCOLOGY | -929.00 | $70.00 | -$65.03K | SELL | -6.16% | 14.14K | Sep 18 | ||
May 02, 2024 | — | 151.00 | $60.15 | -$4.03K | GRANT | 0.31% | 49.34K | Apr 30 - May 01 | ||
May 02, 2024 | CHIEF COMMERCIAL OFFICER | 863.00 | $45.09 | $13.07K | GRANT | 1.85% | 47.61K | Apr 30 - May 01 | ||
May 02, 2024 | SVP, GENERAL COUNSEL & SEC | 741.00 | $45.09 | $19.45K | GRANT | 7.19% | 11.05K | Apr 30 - May 01 | ||
May 02, 2024 | CHIEF FINANCIAL OFFICER | 862.00 | $45.09 | $13.04K | GRANT | 6.89% | 13.38K | Apr 30 - May 01 | ||
May 02, 2024 | EVP, GM., PRECISION ONCOLOGY | 108.00 | $60.15 | -$6.62K | GRANT | 0.79% | 13.73K | Apr 30 - May 01 | ||
May 02, 2024 | EVP, HUMAN RESOURCES | 824.00 | $45.09 | $15.12K | GRANT | 1.06% | 78.34K | Apr 30 - May 01 | ||
May 02, 2024 | GENERAL MANAGER, SCREENING | 116.00 | $60.15 | -$6.14K | GRANT | 0.75% | 15.56K | Apr 30 - May 01 | ||
May 02, 2024 | PRESIDENT AND CEO | 2.04K | $45.09 | -$48.22K | GRANT | 0.17% | 1.18M | Apr 30 - May 01 | ||
Apr 03, 2024 | EVP, HUMAN RESOURCES | -2.00K | $70.00 | -$140.00K | SELL | -2.52% | 77.51K | Apr 01 | ||
Apr 03, 2024 | EVP, GM., PRECISION ONCOLOGY | -924.00 | $79.43 | -$73.39K | SELL | -6.35% | 13.63K | Apr 02 | ||
Apr 01, 2024 | EVP, HUMAN RESOURCES | -2.00K | $70.00 | -$140.00K | SELL | -2.45% | 79.51K | Mar 28 | ||
Mar 04, 2024 | GENERAL MANAGER, SCREENING | 2.57K | $59.32 | -$127.78K | SELL-OPTIONS | 19.97% | 15.44K | Feb 29 - Mar 01 | ||
Mar 04, 2024 | DIRECTOR | -5.00K | $57.50 | -$287.50K | SELL | -17.87% | 22.98K | Mar 01 | ||
Mar 04, 2024 | GENERAL COUNSEL | 1.03K | $59.32 | -$51.13K | SELL-OPTIONS | 11.08% | 10.31K | Feb 29 - Mar 01 | ||
Mar 04, 2024 | CHIEF FINANCIAL OFFICER | 2.88K | $59.32 | -$143.08K | SELL-OPTIONS | 29.87% | 12.52K | Feb 29 - Mar 01 | ||
Mar 04, 2024 | DIRECTOR | -2.00K | $57.50 | -$115.00K | SELL | -3.84% | 50.11K | Mar 01 | ||
Mar 04, 2024 | CHIEF COMMERCIAL OFFICER | 2.88K | $59.32 | -$143.08K | SELL-OPTIONS | 6.56% | 46.75K | Feb 29 - Mar 01 | ||
Mar 04, 2024 | PRESIDENT AND CEO | 9.87K | $59.32 | -$490.64K | SELL-OPTIONS | 0.75% | 1.32M | Feb 29 - Mar 01 | ||
Mar 04, 2024 | EVP, HUMAN RESOURCES | 2.06K | $59.32 | -$102.27K | SELL-OPTIONS | 2.59% | 81.51K | Feb 29 - Mar 01 | ||
Mar 04, 2024 | GEN. MGR., PRECISION ONCOLOGY | 2.40K | $59.32 | -$137.80K | SELL-OPTIONS | 19.76% | 14.55K | Feb 29 - Mar 01 | ||
Feb 28, 2024 | GENERAL MANAGER, SCREENING | 2.08K | $56.89 | -$106.90K | SELL-OPTIONS | 19.22% | 12.87K | Feb 26 - Feb 27 | ||
Feb 28, 2024 | GENERAL COUNSEL | 864.00 | $56.89 | -$44.60K | SELL-OPTIONS | 10.27% | 9.28K | Feb 26 - Feb 27 | ||
Feb 28, 2024 | CHIEF COMMERCIAL OFFICER | 4.03K | $56.89 | -$207.53K | SELL-OPTIONS | 10.12% | 43.87K | Feb 26 - Feb 27 | ||
Feb 28, 2024 | CHIEF FINANCIAL OFFICER | 2.99K | $56.89 | -$154.17K | SELL-OPTIONS | 44.99% | 9.64K | Feb 26 - Feb 27 | ||
Feb 28, 2024 | PRESIDENT AND CEO | 6.92K | $56.89 | -$356.30K | SELL-OPTIONS | 0.53% | 1.31M | Feb 26 - Feb 27 | ||
Feb 28, 2024 | EVP, HUMAN RESOURCES | 2.07K | $56.89 | -$106.95K | SELL-OPTIONS | 2.68% | 79.46K | Feb 26 - Feb 27 | ||
Feb 28, 2024 | GEN. MGR., PRECISION ONCOLOGY | 1.93K | $56.89 | -$115.32K | SELL-OPTIONS | 18.85% | 12.15K | Feb 26 - Feb 27 | ||
Feb 26, 2024 | EVP, HUMAN RESOURCES | -1.02K | $59.72 | -$60.97K | SELL | -1.30% | 77.38K | Feb 23 | ||
Feb 23, 2024 | GENERAL MANAGER, SCREENING | 1.02K | $59.78 | -$60.56K | GRANT | 10.45% | 10.80K | Feb 21 - Feb 22 | ||
Feb 23, 2024 | GENERAL COUNSEL | 290.00 | $59.78 | -$17.40K | GRANT | 3.57% | 8.42K | Feb 21 - Feb 22 | ||
Feb 23, 2024 | CHIEF FINANCIAL OFFICER | 1.36K | $59.78 | -$80.76K | GRANT | 25.72% | 6.65K | Feb 21 - Feb 22 | ||
Feb 23, 2024 | CHIEF COMMERCIAL OFFICER | 1.36K | $59.78 | -$80.70K | GRANT | 3.54% | 39.84K | Feb 21 - Feb 22 | ||
Feb 23, 2024 | DIRECTOR | 1.37K | $59.78 | -$39.63K | GRANT | 2.87% | 49.19K | Feb 21 - Feb 22 | ||
Feb 23, 2024 | PRESIDENT AND CEO | 11.67K | $59.78 | -$691.36K | GRANT | 0.93% | 1.26M | Feb 21 - Feb 22 | ||
Feb 23, 2024 | EVP, HUMAN RESOURCES | 1.02K | $59.78 | -$60.56K | GRANT | 1.32% | 78.41K | Feb 21 - Feb 22 | ||
Feb 23, 2024 | GEN. MGR., PRECISION ONCOLOGY | 941.00 | $59.78 | -$65.34K | GRANT | 10.14% | 10.22K | Feb 21 - Feb 22 | ||
Feb 22, 2024 | GENERAL MANAGER, SCREENING | 1.17K | $61.50 | -$66.30K | SELL-OPTIONS | 13.60% | 9.78K | Feb 20 - Feb 21 | ||
Feb 22, 2024 | GENERAL COUNSEL | 449.00 | $61.50 | -$25.52K | SELL-OPTIONS | 5.85% | 8.13K | Feb 20 - Feb 21 | ||
Feb 22, 2024 | CHIEF FINANCIAL OFFICER | 1.62K | $61.50 | -$91.82K | SELL-OPTIONS | 44.13% | 5.29K | Feb 20 - Feb 21 | ||
Feb 22, 2024 | DIRECTOR | 1.54K | $61.50 | -$43.42K | SELL-OPTIONS | 3.33% | 47.82K | Feb 20 - Feb 21 | ||
Feb 22, 2024 | PRESIDENT AND CEO | 5.40K | $61.50 | -$305.96K | SELL-OPTIONS | 0.43% | 1.25M | Feb 20 - Feb 21 | ||
Feb 22, 2024 | EVP, HUMAN RESOURCES | 1.17K | $61.50 | -$66.36K | SELL-OPTIONS | 1.53% | 77.38K | Feb 20 - Feb 21 | ||
Feb 22, 2024 | GEN. MGR., PRECISION ONCOLOGY | 834.00 | $61.50 | -$55.04K | SELL-OPTIONS | 9.87% | 9.28K | Feb 20 - Feb 21 | ||
Feb 16, 2024 | GENERAL MANAGER, SCREENING | 1.06K | $61.43 | -$59.34K | SELL-OPTIONS | 14.71% | 8.30K | Feb 14 - Feb 15 | ||
Feb 16, 2024 | GENERAL COUNSEL | 530.00 | $45.73 | -$23.82K | SELL-OPTIONS | 7.74% | 7.38K | Oct 31 - Feb 15 | ||
Feb 16, 2024 | CHIEF FINANCIAL OFFICER | 2.08K | $61.43 | -$115.98K | SELL-OPTIONS | 158.72% | 3.40K | Feb 14 - Feb 15 | ||
Feb 16, 2024 | DIRECTOR | 2.60K | $61.43 | -$84.53K | SELL-OPTIONS | 5.94% | 46.27K | Feb 14 - Feb 15 | ||
Feb 16, 2024 | PRESIDENT AND CEO | 17.05K | $45.73 | -$887.33K | SELL-OPTIONS | 1.39% | 1.25M | May 01 - Feb 15 | ||
Feb 16, 2024 | EVP, HUMAN RESOURCES | 1.07K | $61.43 | -$59.28K | SELL-OPTIONS | 1.42% | 75.91K | Feb 14 - Feb 15 | ||
Jan 04, 2024 | EVP, HUMAN RESOURCES | -2.00K | $73.50 | -$147.00K | SELL | -2.60% | 74.85K | Jan 02 | ||
Jan 04, 2024 | GEN. MGR., PRECISION ONCOLOGY | -879.00 | $73.50 | -$64.61K | SELL | -9.59% | 8.29K | Jan 02 | ||
Dec 18, 2023 | EVP, HUMAN RESOURCES | -2.00K | $70.00 | -$140.00K | SELL | -2.54% | 76.85K | Dec 14 | ||
Oct 13, 2023 | CHIEF COMMERCIAL OFFICER | 15.21K | $48.25 | -$843.55K | SELL-OPTIONS | 66.19% | 38.18K | May 01 - Oct 12 | ||
Sep 06, 2023 | EVP, HUMAN RESOURCES | -6.89K | $84.36 | -$379.62K | SELL | -8.04% | 78.85K | Sep 01 | ||
Aug 23, 2023 | CHIEF FINANCIAL OFFICER | -29.24K | $58.80 | -$2.47M | SELL | -95.70% | 1.31K | May 02 - Aug 21 | ||
Aug 08, 2023 | GEN. MGR., PRECISION ONCOLOGY | 1.36K | $85.04 | -$114.80K | SELL-OPTIONS | 17.45% | 9.17K | Aug 04 - Aug 07 | ||
Jul 28, 2023 | DIRECTOR | -2.00K | $97.42 | -$194.84K | SELL | -3.70% | 52.11K | Jul 27 | ||
Jul 21, 2023 | GENERAL COUNSEL | -1.30K | $100.00 | -$130.00K | SELL | -15.96% | 6.84K | Jul 19 | ||
Jun 12, 2023 | DIRECTOR | 2.20K | $90.51 | -$126.90K | GRANT | 4.23% | 54.11K | Jun 08 - Jun 09 | ||
Jun 12, 2023 | DIRECTOR | 572.00 | $90.51 | -$273.97K | GRANT | 0.89% | 64.63K | Jun 08 - Jun 09 | ||
Jun 12, 2023 | GENERAL COUNSEL | -1.30K | $90.00 | -$117.00K | SELL | -13.76% | 8.14K | Jun 08 | ||
May 31, 2023 | DIRECTOR | -2.00K | $80.62 | -$161.24K | SELL | -3.71% | 51.91K | May 26 | ||
May 12, 2023 | EVP, HUMAN RESOURCES | -6.09K | $80.00 | -$486.96K | SELL | -6.63% | 85.74K | May 10 | ||
May 12, 2023 | GENERAL MANAGER, SCREENING | -5.00K | $80.00 | -$400.00K | SELL | -40.86% | 7.24K | May 10 | ||
May 12, 2023 | GENERAL COUNSEL | -660.00 | $54.93 | -$84.59K | SELL | -6.53% | 9.45K | May 01 - May 10 | ||
May 03, 2023 | EVP, HUMAN RESOURCES | -291.00 | $46.90 | -$42.50K | SELL | -0.32% | 91.83K | Apr 30 - May 01 | ||
Apr 05, 2023 | EVP, HUMAN RESOURCES | -1.00K | $67.19 | -$67.19K | SELL | -1.07% | 92.12K | Apr 03 | ||
Mar 07, 2023 | GENERAL MANAGER, SCREENING | -5.00K | $65.00 | -$325.00K | SELL | -29.47% | 11.97K | Mar 03 | ||
Mar 02, 2023 | CHIEF COMMERCIAL OFFICER | -3.63K | $62.01 | -$224.97K | SELL | -13.78% | 22.70K | Mar 01 | ||
Mar 02, 2023 | EVP, HUMAN RESOURCES | -1.00K | $62.00 | -$62.00K | SELL | -1.07% | 92.85K | Mar 01 | ||
Mar 01, 2023 | CHIEF FINANCIAL OFFICER | 4.90K | $61.12 | -$258.72K | SELL-OPTIONS | 19.15% | 30.51K | Feb 27 - Feb 28 | ||
Mar 01, 2023 | GENERAL COUNSEL | -338.00 | $60.43 | -$134.45K | SELL | -3.32% | 9.84K | Feb 27 - Feb 28 | ||
Mar 01, 2023 | GENERAL MANAGER, SCREENING | -2.88K | $60.29 | -$411.87K | SELL | -14.50% | 16.97K | Feb 27 - Feb 28 | ||
Mar 01, 2023 | DIRECTOR | 5.04K | $61.12 | -$253.83K | SELL-OPTIONS | 15.67% | 37.20K | Feb 27 - Feb 28 | ||
Mar 01, 2023 | EVP, HUMAN RESOURCES | 3.39K | $61.12 | -$178.71K | SELL-OPTIONS | 3.74% | 93.85K | Feb 27 - Feb 28 | ||
Mar 01, 2023 | GEN. MGR., PRECISION ONCOLOGY | 2.02K | $61.12 | -$118.08K | SELL-OPTIONS | 35.81% | 7.67K | Feb 27 - Feb 28 | ||
Mar 01, 2023 | PRESIDENT AND CEO | 12.08K | $61.12 | -$636.63K | SELL-OPTIONS | 0.99% | 1.23M | Feb 27 - Feb 28 | ||
Feb 23, 2023 | PRESIDENT AND CEO | 5.61K | $62.72 | -$298.80K | SELL-OPTIONS | 0.46% | 1.22M | Feb 21 - Feb 22 | ||
Feb 23, 2023 | GENERAL COUNSEL | 467.00 | $62.72 | -$24.96K | SELL-OPTIONS | 4.81% | 10.17K | Feb 21 - Feb 22 | ||
Feb 23, 2023 | GENERAL MANAGER, SCREENING | 3.19K | $62.72 | -$169.97K | SELL-OPTIONS | 19.13% | 19.85K | Feb 21 - Feb 22 | ||
Feb 23, 2023 | EVP, HUMAN RESOURCES | 1.22K | $62.72 | -$64.79K | SELL-OPTIONS | 1.36% | 90.46K | Feb 21 - Feb 22 | ||
Feb 23, 2023 | DIRECTOR | 1.24K | $62.72 | -$63.16K | SELL-OPTIONS | 4.01% | 32.16K | Feb 21 - Feb 22 | ||
Feb 23, 2023 | CHIEF FINANCIAL OFFICER | 1.68K | $62.72 | -$89.69K | SELL-OPTIONS | 7.03% | 25.60K | Feb 21 - Feb 22 | ||
Feb 23, 2023 | GEN. MGR., PRECISION ONCOLOGY | 891.00 | $62.72 | -$52.56K | SELL-OPTIONS | 18.74% | 5.65K | Feb 21 - Feb 22 | ||
Feb 17, 2023 | EVP, HUMAN RESOURCES | -1.08K | $63.91 | -$68.77K | SELL | -1.19% | 89.25K | Feb 16 | ||
Feb 16, 2023 | GENERAL COUNSEL | 483.00 | $65.59 | -$26.24K | SELL-OPTIONS | 5.24% | 9.71K | Feb 14 - Feb 15 | ||
Feb 16, 2023 | EVP, HUMAN RESOURCES | 1.08K | $65.59 | -$62.57K | SELL-OPTIONS | 1.21% | 90.32K | Feb 14 - Feb 15 | ||
Feb 16, 2023 | GENERAL MANAGER, SCREENING | 1.08K | $69.59 | -$66.39K | SELL-OPTIONS | 6.90% | 16.66K | Feb 14 - Feb 15 | ||
Feb 16, 2023 | DIRECTOR | 2.15K | $65.59 | -$119.44K | SELL-OPTIONS | 7.48% | 30.92K | Feb 14 - Feb 15 | ||
Feb 16, 2023 | CHIEF FINANCIAL OFFICER | 2.11K | $65.59 | -$122.39K | SELL-OPTIONS | 9.65% | 23.92K | Feb 14 - Feb 15 | ||
Feb 16, 2023 | PRESIDENT AND CEO | 16.52K | $65.59 | -$958.73K | SELL-OPTIONS | 1.38% | 1.21M | Feb 14 - Feb 15 | ||
Feb 14, 2023 | CHIEF FINANCIAL OFFICER | 1.42K | $64.55 | -$74.75K | SELL-OPTIONS | 6.97% | 21.82K | Feb 10 - Feb 13 | ||
Feb 14, 2023 | PRESIDENT AND CEO | 5.18K | $64.55 | -$292.22K | SELL-OPTIONS | 0.44% | 1.19M | Feb 10 - Feb 13 | ||
Feb 03, 2023 | EVP, HUMAN RESOURCES | -1.00K | $67.93 | -$67.93K | SELL | -1.11% | 89.25K | Feb 01 | ||
Jan 11, 2023 | EVP, HUMAN RESOURCES | -672.00 | $53.70 | -$44.45K | SELL | -0.74% | 90.25K | May 02 - Jan 09 | ||
Oct 13, 2022 | CHIEF COMMERCIAL OFFICER | 18.65K | $39.39 | -$504.62K | SELL-OPTIONS | ∞ | 18.65K | May 02 - Oct 12 | ||
Aug 08, 2022 | GEN. MGR., PRECISION ONCOLOGY | 1.73K | $47.12 | -$46.37K | SELL-OPTIONS | 57.09% | 4.75K | Aug 04 - Aug 05 | ||
Jul 28, 2022 | DIRECTOR | 0.00 | $27.66 | -$161.10K | SELL-OPTIONS | 0.00% | 64.06K | Jul 26 | ||
Jul 06, 2022 | PRESIDENT AND CEO | 321.00 | $44.08 | $15.27K | GRANT | 0.03% | 1.19M | May 02 - Jul 01 | ||
Jul 01, 2022 | DIRECTOR | -1.09K | $40.13 | -$43.58K | SELL | -1.67% | 64.06K | Jun 30 | ||
Mar 02, 2022 | EVP, HUMAN RESOURCES | 3.06K | $76.69 | -$215.96K | SELL-OPTIONS | 3.50% | 90.68K | Feb 28 - Mar 01 | ||
Mar 02, 2022 | PRESIDENT AND CEO | 15.59K | $76.69 | -$1.10M | SELL-OPTIONS | 1.66% | 952.71K | Feb 28 - Mar 01 | ||
Mar 02, 2022 | CHIEF LEGAL OFFICER | 4.38K | $76.69 | -$300.01K | SELL-OPTIONS | 27.26% | 20.43K | Feb 28 - Mar 01 | ||
Mar 02, 2022 | CHIEF FINANCIAL OFFICER | 4.41K | $76.69 | -$310.59K | SELL-OPTIONS | 27.74% | 20.32K | Feb 28 - Mar 01 | ||
Mar 01, 2022 | SVP, HUMAN RESOURCES | -5.48K | $74.19 | -$406.54K | SELL | -5.89% | 87.62K | Feb 25 | ||
Feb 25, 2022 | SVP, HUMAN RESOURCES | 5.48K | $70.10 | -$330.66K | SELL-OPTIONS | 6.25% | 93.10K | Feb 23 - Feb 24 | ||
Feb 25, 2022 | PRESIDENT AND CEO | 31.52K | $70.10 | -$1.90M | SELL-OPTIONS | 3.48% | 937.13K | Feb 23 - Feb 24 | ||
Feb 25, 2022 | CHIEF ADMINISTRATIVE OFFICER | 6.93K | $70.10 | -$407.63K | SELL-OPTIONS | 76.01% | 16.05K | Feb 23 - Feb 24 | ||
Feb 25, 2022 | CHIEF FINANCIAL OFFICER | 6.85K | $70.10 | -$413.38K | SELL-OPTIONS | 75.64% | 15.91K | Feb 23 - Feb 24 | ||
Feb 25, 2022 | GENERAL MANAGER, NEW VENTURES | 5.48K | $70.10 | -$330.66K | SELL-OPTIONS | 55.53% | 15.35K | Feb 23 - Feb 24 | ||
Feb 24, 2022 | CHIEF FINANCIAL OFFICER | 1.55K | $69.05 | -$107.51K | SELL-OPTIONS | 20.73% | 9.06K | Feb 22 - Feb 23 | ||
Feb 24, 2022 | SVP, HUMAN RESOURCES | 1.12K | $69.05 | -$77.61K | SELL-OPTIONS | 1.30% | 87.62K | Feb 22 - Feb 23 | ||
Feb 24, 2022 | PRESIDENT AND CEO | 5.18K | $69.05 | -$358.23K | SELL-OPTIONS | 0.58% | 905.61K | Feb 22 - Feb 23 | ||
Feb 24, 2022 | GENERAL MANAGER, NEW VENTURES | 1.12K | $69.05 | -$77.68K | SELL-OPTIONS | 12.83% | 9.87K | Feb 22 - Feb 23 | ||
Feb 24, 2022 | CHIEF ADMINISTRATIVE OFFICER | 1.14K | $69.05 | -$76.58K | SELL-OPTIONS | 14.26% | 9.12K | Feb 22 - Feb 23 | ||
Feb 23, 2022 | GENERAL MANAGER, NEW VENTURES | 1.90K | $73.42 | $143.31K | SELL-OPTIONS | 27.75% | 8.75K | Feb 18 - Feb 22 | ||
Feb 16, 2022 | SVP, HUMAN RESOURCES | 1.09K | $78.94 | $84.39K | SELL-OPTIONS | 1.28% | 86.50K | Feb 14 - Feb 15 | ||
Feb 16, 2022 | CHIEF FINANCIAL OFFICER | 2.13K | $78.94 | $164.83K | SELL-OPTIONS | 39.74% | 7.50K | Feb 14 - Feb 15 | ||
Feb 16, 2022 | PRESIDENT AND CEO | 207.91K | $49.54 | $3.20M | SELL-OPTIONS | 30.02% | 900.42K | Feb 14 - Feb 15 | ||
Feb 16, 2022 | GENERAL MANAGER, NEW VENTURES | 1.09K | $78.94 | $84.23K | SELL-OPTIONS | 18.93% | 6.85K | Feb 14 - Feb 15 | ||
Feb 16, 2022 | CHIEF ADMINISTRATIVE OFFICER | 2.49K | $78.42 | $188.14K | SELL-OPTIONS | 45.26% | 7.98K | Apr 30 - Feb 15 | ||
Nov 03, 2021 | PRESIDENT AND CEO | -16.92K | $93.88 | -$1.59M | SELL | -2.41% | 686.11K | Nov 01 | ||
Oct 05, 2021 | PRESIDENT AND CEO | -17.08K | $93.64 | -$1.60M | SELL | -2.37% | 703.03K | Oct 01 | ||
Sep 03, 2021 | PRESIDENT AND CEO | -18.98K | $104.42 | -$1.98M | SELL | -2.57% | 720.11K | Sep 01 | ||
Aug 04, 2021 | PRESIDENT AND CEO | -19.97K | $107.50 | -$2.15M | SELL | -2.63% | 739.09K | Aug 02 | ||
Aug 02, 2021 | CHIEF FINANCIAL OFFICER | -38.16K | $107.31 | -$4.25M | SELL | -96.47% | 1.40K | Apr 30 - Jul 29 | ||
Aug 02, 2021 | DIRECTOR | -1.38K | $111.11 | -$153.44K | SELL | -2.27% | 59.54K | Jul 30 | ||
Aug 02, 2021 | DIRECTOR | -2.64K | $111.17 | -$293.49K | SELL | -8.13% | 29.83K | Jul 30 | ||
Jul 06, 2021 | PRESIDENT AND CEO | -7.78K | $123.43 | -$960.78K | SELL | -1.02% | 759.06K | Jul 01 | ||
Jun 11, 2021 | SVP, HUMAN RESOURCES | -3.17K | $66.81 | -$622.96K | SELL | -4.02% | 75.80K | Apr 30 - Jun 10 | ||
Jun 03, 2021 | PRESIDENT AND CEO | -12.38K | $111.00 | -$1.37M | SELL | -1.59% | 766.84K | Jun 01 | ||
Jun 03, 2021 | DIRECTOR | -17.00K | $108.11 | -$1.84M | SELL | -76.26% | 5.29K | Jun 02 | ||
May 05, 2021 | PRESIDENT AND CEO | -18.91K | $97.91 | -$2.50M | SELL | -2.37% | 779.23K | Apr 30 - May 03 | ||
Apr 05, 2021 | PRESIDENT AND CEO | -22.75K | $132.30 | -$3.01M | SELL | -2.77% | 798.14K | Apr 01 | ||
Mar 15, 2021 | CHIEF SCIENCE OFFICER | 0.00 | $78.03 | -$4.49M | SELL-OPTIONS | 0.00% | 43.04K | Mar 11 | ||
Mar 08, 2021 | CHIEF SCIENCE OFFICER | -11.73K | $121.33 | -$1.42M | SELL | -23.39% | 38.43K | Mar 05 | ||
Mar 05, 2021 | CHIEF FINANCIAL OFFICER | -2.63K | $135.02 | -$355.37K | SELL | -6.24% | 39.55K | Mar 03 | ||
Mar 05, 2021 | CHIEF ADMINISTRATIVE OFFICER | -2.66K | $135.02 | -$359.69K | SELL | -32.65% | 5.50K | Mar 03 | ||
Mar 03, 2021 | CHIEF SCIENCE OFFICER | 2.50K | $138.42 | -$349.37K | SELL-OPTIONS | 5.25% | 50.16K | Mar 01 - Mar 02 | ||
Mar 03, 2021 | CHIEF FINANCIAL OFFICER | 795.00 | $139.24 | -$588.99K | SELL-OPTIONS | 1.92% | 42.14K | Mar 01 - Mar 02 | ||
Mar 03, 2021 | CHIEF ADMINISTRATIVE OFFICER | 899.00 | $139.23 | -$574.46K | SELL-OPTIONS | 12.59% | 8.04K | Mar 01 - Mar 02 | ||
Mar 03, 2021 | PRESIDENT AND CEO | 10.78K | $138.42 | -$1.36M | SELL-OPTIONS | 1.33% | 820.89K | Mar 01 - Mar 02 | ||
Mar 03, 2021 | SVP, HUMAN RESOURCES | 1.85K | $138.42 | -$232.41K | SELL-OPTIONS | 2.40% | 78.85K | Mar 01 - Mar 02 | ||
Mar 02, 2021 | DIRECTOR | -8.91K | $78.55 | -$2.20M | SELL | -77.70% | 2.56K | Feb 26 | ||
Mar 02, 2021 | CHIEF SCIENCE OFFICER | 1.66K | $137.44 | -$220.32K | SELL-OPTIONS | 3.61% | 47.66K | Feb 26 - Mar 01 | ||
Mar 02, 2021 | CHIEF FINANCIAL OFFICER | -4.97K | $136.91 | -$1.15M | SELL | -10.72% | 41.34K | Feb 26 - Mar 01 | ||
Mar 02, 2021 | SVP, HUMAN RESOURCES | 1.26K | $137.44 | -$150.91K | SELL-OPTIONS | 1.66% | 77.01K | Feb 26 - Mar 01 | ||
Mar 02, 2021 | DIRECTOR | -2.00K | $130.11 | -$260.22K | SELL | -6.16% | 30.46K | Feb 26 | ||
Mar 02, 2021 | CHIEF ADMINISTRATIVE OFFICER | 1.76K | $90.67 | -$591.74K | SELL-OPTIONS | 32.84% | 7.14K | Feb 26 - Mar 01 | ||
Mar 02, 2021 | PRESIDENT AND CEO | -21.98K | $136.88 | -$4.28M | SELL | -2.64% | 810.11K | Feb 26 - Mar 01 | ||
Mar 01, 2021 | CHIEF ADMINISTRATIVE OFFICER | -6.79K | $132.96 | -$902.53K | SELL | -55.81% | 5.37K | Feb 25 | ||
Feb 25, 2021 | CHIEF SCIENCE OFFICER | 5.73K | $136.30 | -$796.26K | SELL-OPTIONS | 14.24% | 46.00K | Feb 23 - Feb 24 | ||
Feb 25, 2021 | CHIEF FINANCIAL OFFICER | 4.85K | $136.30 | -$606.40K | SELL-OPTIONS | 11.70% | 46.31K | Feb 23 - Feb 24 | ||
Feb 25, 2021 | CHIEF ADMINISTRATIVE OFFICER | 6.79K | $79.07 | -$2.98M | SELL-OPTIONS | 126.31% | 12.16K | Feb 23 - Feb 24 | ||
Feb 25, 2021 | PRESIDENT AND CEO | 17.91K | $136.30 | -$2.24M | SELL-OPTIONS | 2.20% | 832.09K | Feb 23 - Feb 24 | ||
Feb 25, 2021 | SVP, HUMAN RESOURCES | 2.24K | $136.30 | -$280.37K | SELL-OPTIONS | 3.05% | 75.75K | Feb 23 - Feb 24 | ||
Feb 22, 2021 | GENERAL MANAGER, NEW VENTURES | 1.95K | $143.38 | -$243.17K | SELL-OPTIONS | 53.03% | 5.64K | Feb 18 - Feb 19 | ||
Feb 22, 2021 | CHIEF ADMINISTRATIVE OFFICER | -1.98K | $140.79 | -$278.76K | SELL | -26.92% | 5.37K | Feb 18 | ||
Feb 18, 2021 | GENERAL MANAGER, NEW VENTURES | 997.00 | $142.66 | -$147.37K | SELL-OPTIONS | 37.12% | 3.68K | Feb 16 - Feb 17 | ||
Feb 18, 2021 | CHIEF SCIENCE OFFICER | 1.84K | $142.66 | -$304.01K | SELL-OPTIONS | 4.79% | 40.27K | Feb 16 - Feb 17 | ||
Feb 18, 2021 | CHIEF FINANCIAL OFFICER | 1.95K | $142.66 | -$288.17K | SELL-OPTIONS | 4.94% | 41.46K | Feb 16 - Feb 17 | ||
Feb 18, 2021 | CHIEF ADMINISTRATIVE OFFICER | 1.98K | $142.66 | -$284.18K | SELL-OPTIONS | 36.84% | 7.35K | Feb 16 - Feb 17 | ||
Feb 18, 2021 | PRESIDENT AND CEO | 15.31K | $142.66 | -$2.26M | SELL-OPTIONS | 1.92% | 814.19K | Feb 16 - Feb 17 | ||
Feb 18, 2021 | SVP, HUMAN RESOURCES | 997.00 | $142.66 | -$147.37K | SELL-OPTIONS | 1.38% | 73.50K | Feb 16 - Feb 17 | ||
Feb 03, 2021 | PRESIDENT AND CEO | -66.09K | $138.07 | -$4.19M | SELL | -7.80% | 781.34K | Dec 28 - Feb 01 | ||
Jan 07, 2021 | PRESIDENT AND CEO | -31.81K | $128.74 | -$4.10M | SELL | -3.62% | 847.43K | Jan 04 | ||
Dec 14, 2020 | — | -20.00K | $132.06 | -$2.64M | SELL | -25.35% | 58.91K | Dec 14 | ||
Dec 02, 2020 | — | -30.58K | $124.56 | -$3.81M | SELL | -3.36% | 879.25K | Dec 01 | ||
Nov 03, 2020 | — | -32.82K | $121.11 | -$3.97M | SELL | -3.48% | 909.82K | Nov 02 | ||
Oct 02, 2020 | — | -27.43K | $103.55 | -$2.84M | SELL | -2.83% | 942.64K | Oct 01 | ||
Sep 28, 2020 | — | 0.00 | $60.77 | -$169.31K | OPTION EXERCISE | 0.00% | 2.02K | Sep 24 | ||
Sep 02, 2020 | — | -19.93K | $75.03 | -$1.50M | SELL | -2.01% | 970.07K | Sep 01 |
FAQ
Est-ce que le trading d'initiés est légal ?
Le trading d'initiés est légal tant que les initiés signalent ces transactions à la SEC. Le trading de titres illégal se produit lorsque l'initié enfreint un devoir fiduciaire ou omet de signaler ses transactions.
Quels sont quelques exemples de manipulation de marché ?
Le trading d'initiés, les schémas de gonflement et de vidage, le front running et les opérations de lavage sont tous des exemples de manipulation de marché. Les investisseurs qui suivent les mouvements d'actifs des initiés devraient réfléchir attentivement à la raison pour laquelle ces initiés échangent leurs actions avant de passer à l'action.
Parcourir transactions d'initiés sur toutes les actions.